Indications and uses
temporarily relieves minor pain
temporarily relieves minor pain
adults and children over 12 years : apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period children 12 years and younger : ask a doctor
Drug Facts
Lidocaine HCI 4%
Topical anesthetic
temporarily relieves minor pain
For external use only
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
adults and children over 12 years:
children 12 years and younger: ask a doctor
acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, methylparaben, steareth-21, water
ODOR FREE
Aspercreme
WITH 4% LIDOCAINE
MAXIMUM STRENGTH
Pain Relieving CREME
Net wt 2.7 oz (76.5 g)
ODOR FREE
Aspercreme
WITH 4% LIDOCAINE
MAXIMUM STRENGTH
Pain Relieving CREME
Net wt 4.3 oz (121 g)
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-0582-1 | Aspercreme with Lidocaine Pain Relieving Creme | 121 g in 1 BOTTLE | LOTION | 121 | 14 | |
| 41167-0582-1 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-2 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-2 | Aspercreme with Lidocaine Pain Relieving Creme | 49.6 g in 1 TUBE | LOTION | 49.6 | 14 | |
| 41167-0582-4 | Aspercreme with Lidocaine Pain Relieving Creme | 113 g in 1 BOTTLE | LOTION | 113 | 14 | |
| 41167-0582-4 | Aspercreme with Lidocaine Pain Relieving Creme | 2 in 1 CARTON | LOTION | 2 | 14 | |
| 41167-0582-5 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-5 | Aspercreme with Lidocaine Pain Relieving Creme | 76.5 g in 1 BOTTLE | LOTION | 76.5 | 14 | |
| 41167-0582-8 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0582-8 | Aspercreme with Lidocaine Pain Relieving Creme | 133 g in 1 BOTTLE | LOTION | 133 | 14 | |
| 41167-0587-7 | Aspercreme with Lidocaine Pain Relieving Creme | 76.5 g in 1 BOTTLE | LOTION | 76.5 | 14 | |
| 41167-0587-7 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0587-8 | Aspercreme with Lidocaine Pain Relieving Creme | 1 in 1 CARTON | LOTION | 1 | 14 | |
| 41167-0587-8 | Aspercreme with Lidocaine Pain Relieving Creme | 49.6 g in 1 TUBE | LOTION | 49.6 | 14 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41167-0582 | ASPERCREME WITH LIDOCAINE PAIN RELIEVING CREME (LIDOCAINE HYDROCHLORIDE) LOTION [CHATTEM, INC.] | 14 | Current NDC, Legacy NDC, 10 package rows | 20250302_d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd.zip |
| 41167-0587 | ASPERCREME WITH LIDOCAINE PAIN RELIEVING CREME (LIDOCAINE HYDROCHLORIDE) LOTION [CHATTEM, INC.] | 14 | Current NDC, 4 package rows | 20250302_d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-0582-2 | GM - Gram | 41167-0582 | e21f60c8-faf1-4247-a807-ffe2d95ec4e9 | 1 | 2021-08-05 |
| 41167-0582-5 | GM - Gram | 41167-0582 | d7371561-be61-41ab-a79d-fb9e4a80e592 | 1 | 2020-04-20 |
| 41167-0582-8 | GM - Gram | 41167-0582 | 3c72626a-9fd8-49ef-872a-d9c37ab432c3 | 1 | 2020-09-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | 1 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| AMINOMETHYLPROPANOL | INACTIVE INGREDIENT | LU49E6626Q | 1 | |
| CAPRYLYL TRISILOXANE | INACTIVE INGREDIENT | Q95M2P1KJL | 1 | |
| CETETH-20 PHOSPHATE | INACTIVE INGREDIENT | 921FTA1500 | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| DIHEXADECYL PHOSPHATE | INACTIVE INGREDIENT | 2V6E5WN99N | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| STEARETH-21 | INACTIVE INGREDIENT | 53J3F32P58 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-0582 | 41167-0582-5, 41167-0582-2, 41167-0582-8, 41167-0582-4, 41167-0582-1 |
| 41167-0587 | 41167-0587-7, 41167-0587-8 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| STEARETH-21 | STEARETH-21 | 53J3F32P58 | LOTION / TOPICAL | 3 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| AMINOMETHYLPROPANOL | AMINOMETHYLPROPANOL | LU49E6626Q | LOTION / TOPICAL | 0.3 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspercreme with Lidocaine Pain Relieving Creme | LIDOCAINE HYDROCHLORIDE | Chattem, Inc. | d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd | 2024-05-01 | Warnings | 41167-0582-1 41167-0582-4 41167-0587-7 41167-0582-2 41167-0582-8 41167-0582-5 41167-0587-8 41167-0582 41167-0587 41167058205 41167058201 41167058202 41167058204 41167058708 41167058707 41167058208 6785c38d-594d-434d-b6f7-41b6190c8ba6 d5da67c3-c2ec-4e3e-abe9-cc862dcfc8bd |
Adverse event summaries are temporarily unavailable. Other product information remains available.